FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Verena von Richthofen

Research Profile

Disorders

Anatomy

Muscle, Skeletal

Phenomena

Muscle Contraction

Chemicals & Drugs

Concepts & Ideas

Procedures

Culture Techniques

Co-author Network

Publications

TOP 3
Franziska von Breunig; Frank Wappler; Christian Hagel; Verena von Richthofen; Marko Fiege; Ralf Weisshorn; Dimitrios Stavrou; Jochen Schulte am Esch
Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients.
Marko Fiege; Frank Wappler; Jens Scholz; Ralf Weisshorn; Verena von Richthofen; Jochen Schulte am Esch
Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
Marko Fiege; Frank Wappler; Jens Scholz; Verena von Richthofen; B Brinken; Jochen Schulte am Esch
[Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Verena von Richthofen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Franziska von Breunig; Frank Wappler; Christian Hagel; Verena von Richthofen; Marko Fiege; Ralf Weisshorn; Dimitrios Stavrou; Jochen Schulte am Esch
Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients.
Anesthesiology 2004;100(4):789-94.
2000: Marko Fiege; Frank Wappler; Jens Scholz; Ralf Weisshorn; Verena von Richthofen; Jochen Schulte am Esch
Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
Journal of clinical anesthesia 2000;12(2):123-8.
1998: Marko Fiege; Frank Wappler; Jens Scholz; Verena von Richthofen; B Brinken; Jochen Schulte am Esch
[Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1998;33(9):557-63.
1998: Frank Wappler; Jens Scholz; Verena von Richthofen; Marko Fiege; A Köchling; J Matschke; G Winkler; Jochen Schulte am Esch
[Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1998;33(6):373-80.
1998: Verena von Richthofen; Frank Wappler; Jens Scholz; Marko Fiege; Jochen Schulte am Esch
[Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale].
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1998;33(4):244-9.
1997: Frank Wappler; Jens Scholz; Verena von Richthofen; Marko Fiege; A Köchling; W Lambrecht; Jochen Schulte am Esch
Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.
Acta anaesthesiologica Scandinavica 1997;41(10):1312-8.
1997: Frank Wappler; Jens Scholz; Verena von Richthofen; Marko Fiege; Markus Steinfath; Jochen Schulte am Esch
[4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1997;32(9):541-8.
1997: Frank Wappler; Jens Scholz; S Oppermann; Verena von Richthofen; Markus Steinfath; Jochen Schulte am Esch
Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
Journal of clinical anesthesia 1997;9(4):306-11.